J.D. Posillico Inc.

MedImmune Strikes Deal With Elusys; Earnings Drop Shares.
BIOWORLD Today; 11/3/2009; 1265 words; ...Elusys Therapeutics Inc. Gaithersburg, Md...and CEO Elizabeth Posillico noted that it's...with such R&D continuing independently...viral pathogens, Posillico said. Elusys, which...MedImmune Ventures Inc., is making an undisclosed...in Pine Brook, N.J., are designed to...

Elusys' Series D Extended To $23M For HP Antibodies.
BIOWORLD Today; 11/3/2009; 878 words; ...Elusys Therapeutics Inc. pulled in $11...extension of its Series D financing to raise...with MedImmune Inc. Made up of a...said Elizabeth Posillico, president and...Pine Brook, N.J.-based Elusys...approaches," Posillico said, noting that...known as Erythromed Inc., takes its ...

Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study.
PR Newswire; 4/20/2009; 997 words; ...PINE BROOK, N.J., April 20 /PRNewswire...Elusys Therapeutics, Inc. (Elusys), a privately...database. Elizabeth Posillico, Ph.D., President and...pharmacokinetic data." Dr. Posillico added, "Death from...selected to R&D Directions' list...

NEW JERSEY INSTITUTE OF TECHNOLOGY FACULTY, STUDENTS TO PRESENT NEW RESEARCH AT 2009 ADVANCE SHOWCASE
US Fed News Service, Including US State News; 3/24/2009; 336 words; NEWARK, N.J., March 23 -- New Jersey Institute of Technology...Biomedical Engineering Program Director; and Elizabeth Posillico, Ph,D, president and CEO, Elusys Therapeutics, Inc.For more information please contact: Sarabjit Jagirdar...

BioNJ Elects New Officers.
Business Wire; 1/23/2009; 2401 words; ...of ImClone Systems, Inc.; Mr. Marucci; and Christopher J. Schaber, Ph.D., President and CEO...PTC Therapeutics, Inc.; Elizabeth G. Posillico, Ph.D., President and CEO of Elusys Therapeutics, Inc.; and Gary Reedy...